8781/13381US=23 / Câncer
Hayat MA. Breast cancer: an introduction. In: ___. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 1-3. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. INTRODUCAO


8782/13381US=23 / Câncer
Zheng B. Breast cancer: computer-aided detection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 5-27. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DETECCAO; COMPUTADOR; CAD; DIAGNOSTICO AUXILIADO POR COMPUTADOR


8783/13381US=23 / Câncer
Hisaoka M, Hamada T. Sebaceous carcinoma of the breast: clinicopathologic features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 29-32. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA SEBACEO DA MAMA; CARACTERISTICAS CLINICO-PATOLOGICAS


8784/13381US=28 / Biol/Mol
Kerbel RS, Emmenegger U, Folkins C, Munoz R, Shaked Y. Metronomic low-dose antiangiogenic chemotherapy in mice and man. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 277-96. ISBN 978-1-58829-870-6.

BAIXA DOSE DE QUIMIOTERAPIA; ANGIOGENESE TUMORAL; TERAPIA ANTIANGIOGENICA; ENSAIOS CLINICOS; CELULAS PROGENITORAS ENDOTELIAIS; VEGF; METASTASE; CANCER DE MAMA; CANCRO DO OVARIO; CICLOFOSFAMIDA


8785/13381US=28 / Biol/Mol
Siemann DW, Horsman MR. Small-molecule vascular disrupting agents in cancer therapy. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 297-310. ISBN 978-1-58829-870-6.

8786/13381US=23 / Câncer
Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA


8787/13381US=28 / Biol/Mol
Mendoza E, Burd R, Wachsberger P, Dicker AP. Normalization of tumor vasculature and improvement of radiation response by antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 311-21. ISBN 978-1-58829-870-6.

ANGIOGENESE; AGENTES ANTI-ANGIOGENICOS; CANCER; CLINICO; PRE-CLINICO; NORMALIZACAO; TUMOR; RESPOSTA RADIACAO; TERAPIA DE RADIACAO; OXIGENACAO DO TUMOR; VASCULATURA


8788/13381US=28 / Biol/Mol
Ellis LM, Dallas NA, Buren II GV, Lim S, Xia L, Fan F, Gray MJ. Challenges in translating antiangiogenic therapy from the bench to bedside. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 323-30. ISBN 978-1-58829-870-6.

ANGIOGENESE; FARMACOCINETICA; DOSE MAXIMA TOLERADA; INTEGRIDADE; INVESTIGACAO TRANSLACIONAL


8789/13381US=28 / Biol/Mol
Han L, Lorincz AM, Sukumar S. Regulation of angiogenesis in cancer and its therapeutic implications. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 331-49. ISBN 978-1-58829-870-6.

ANGIOGENESE; VEGF; SAGE; CANCER; ANTIANGIOGENICO


8790/13381US=23 / Câncer
Mattie MD, Getts RC. Breast and prostate biopsies: use of optimized high-throughput microRNA expression for diagnosis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 43-59. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; BIOPSIAS; USO DE EXPRESSAO DE MICRORNA; METODOLOGIA


8791/13381US=28 / Biol/Mol
DuBois S, Demetri G. Angiogenesis and angiogenesis inhibition in sarcomas. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 353-69. ISBN 978-1-58829-870-6.

SARCOMA; ANGIOGENESE; MESENQUIMAL; VEGF


8792/13381US=28 / Biol/Mol
Grothey A. Antiangiogenesis agents in colorectal cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 371-84. ISBN 978-1-58829-870-6.

CANCER COLORRETAL; QUIMIOTERAPIA; BEVACIZUMAB; VEGF; EGFR


8793/13381US=23 / Câncer
Bult P, Hoogerbrugge N. Familial breast cancer: detection of prevalent high-risk epithelial lesions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 61-71. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA FAMILIAR; CARCINOMA LOBULAR IN SITU; HIPERPLASIA LOBULAR ATIPICA; CARCINOMA DUCTAL IN SITU; HIPERPLASIA DUCTAL ATIPICA


8794/13381US=28 / Biol/Mol
Warren KE, Fine HA. Antiangiogenic therapy for primary CNS tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 385-408. ISBN 978-1-58829-870-6.

GLIOMA; GLIOBLASTOMA; ASTROCITOMA; MEDULOBLASTOMA; QUIMIOTERAPIA; VASCULATURA


8795/13381US=28 / Biol/Mol
Nilsson MB, Hanraban EO, Heymach JV. Angiogenesis inhibitors for the treatment of lung cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 409-26. ISBN 978-1-58829-870-6.

CANCER DE PULMAO; ANGIOGENESE; INIBIDORES DA ANGIOGENESE


8796/13381US=28 / Biol/Mol
Gordon MS, Ebbinghaus SW. Antiangiogenic therapy of renal cell carcinoma. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 427-39. ISBN 978-1-58829-870-6.

CARCINOMA DE CELULAS RENAIS; CANCER DE RIM; ANTI ANGIOGENICA; TERAPIA-ALVO


8797/13381US=28 / Biol/Mol
Burger RA. Antiangiogenesis therapies in gynecologic malignancies. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 441-56. ISBN 978-1-58829-870-6.

QUIMIOTERAPIA; GLIOMA; GLIOBLASTOMA; ASTROCITOMA; MEDULOBLASTOMA; VASCULATURA


8798/13381US=23 / Câncer
Tang APY, Tse GMK, Lam WWM. Differentiation between benign and malignant papillary lesions of breast: excisional biopsy or stereotactic vacuum-assisted biopsy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 73-97. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; LESOES BENIGNAS PAPILARES DE MAMA; LESOES MALIGNAS PAPILARES DE MAMA; BIOPSIA EXCISIONAL; BIOPSIA VACUO-ASSISTIDA; BIOPSIA ASSISTIDA POR VACUO; CARCINOMA DUCTAL; ASPIRACAO POR AGULHA FINA; BIOPSIA POR AGULHA; BIOPSIA EXCISIONAL; ESTEREOTAXIA; ULTRASSOM


8799/13381US=28 / Biol/Mol
Melchert M, List AF. Antiangiogenic agents in myeloid malignancies. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 457-73. ISBN 978-1-58829-870-6.

SINDROMES MIELODISPLASICAS; LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MIELOIDE CRONICA; DOENCAS REUMATICAS; ANGIOGENESE; NEOVASCULARIZCAO; VEGF


8800/13381US=23 / Câncer
Knauer M, Konstantiniuk P, Haid A, Wenzl E, Koberle-Wuhrer R, Riegler-Keil M, Postlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: sentinel node biopsy as a diagnostic tool. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 99-108. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA MULTICENTRICO; BIOPSIA DE LINFONODO SENTINELA


Primeira | Anterior | Próxima | Última